Search all medical codes

Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use

CPT4 code

Name of the Procedure:

Diphtheria, Tetanus Toxoids, Acellular Pertussis Vaccine, Haemophilus Influenzae Type B, and Inactivated Poliovirus Vaccine (DTaP-IPV/Hib), for Intramuscular Use

Summary

This procedure involves administering a combination vaccine via an intramuscular injection. The vaccine protects against five serious diseases: diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type b (Hib), and poliomyelitis (polio).

Purpose

The vaccine is used to prevent diphtheria, tetanus (lockjaw), pertussis (whooping cough), infections caused by Haemophilus influenzae type b, and polio. The goal is to immunize infants and young children to protect them from these potentially life-threatening diseases.

Indications

  • Infants and young children typically starting at 2 months of age.
  • Anyone with no prior immunization or incomplete vaccination schedule for these diseases.

Preparation

  • No special preparation is usually necessary.
  • Ensure the child is in good health to avoid potential complications.
  • Inform the healthcare provider about any allergies or previous adverse reactions to vaccines.

Procedure Description

  1. The healthcare provider will prepare the vaccine dose.
  2. The vaccine is administered as an intramuscular injection, usually in the thigh for young children.
  3. The skin is cleaned, and the injection is given using a sterile needle.
  4. After the administration, the area is observed for a brief period to monitor for any immediate reactions.

Duration

The injection itself takes only a few seconds.

Setting

The procedure is typically performed in a pediatric clinic, outpatient clinic, or doctor's office.

Personnel

  • Pediatrician or family physician
  • Nurse or medical assistant

Risks and Complications

  • Common risks: mild fever, redness, swelling at the injection site, fussiness, and fatigue.
  • Rare risks: severe allergic reactions, high fever, seizures.
  • Complications are usually managed with supportive care or medication.

Benefits

  • Protection against five serious diseases.
  • Long-term immunity through the vaccination schedule.
  • Reduction in the incidence of these diseases within the community.

Recovery

  • Post-procedure care includes monitoring the injection site for any redness or swelling.
  • Child may return to normal activities immediately.
  • Maintain a schedule for follow-up doses as recommended by the healthcare provider.

Alternatives

  • Separate vaccinations for each disease, though this may require more injections and clinic visits.
  • Benefits of the combination vaccine include fewer injections and convenience.

Patient Experience

  • The child may feel a brief sting or discomfort during the injection.
  • Pain at the injection site can be managed with a cold compress or over-the-counter pain relievers.
  • Most children experience only mild side effects, if any.

Medical Policies and Guidelines for Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use

Related policies from health plans

Similar Codes